Females have been reported to carry a higher frequency of mutations in critical driver genes such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), Kirsten rat sarcoma (KRAS) genes, and tumor protein 53 (TP53), thereby increasing susceptibility to adenocarcinoma [8,34]. This evidence concerns the gene TP53 and adenocarcinoma.